🔓 Unlock the full profile of Chris Crisman (Tissium), including verified contact details, financial insights, and professional associations.

See Chris Crisman Full Profile

Below are the ✅ Verified Contact Details to help you connect directly:

Email: chr*****@tis******.com

Mobile: 94445*****

Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)

Key Insights You Should Know About This Individual

  • Chris Crisman is currently a Co-Founder at TISSIUM, an organization founded in 2013 that specializes in advanced biomaterials for medical applications.
  • As Co-Founder, Crisman is instrumental in shaping TISSIUM's vision and strategic direction, focusing on the development of innovative solutions aimed at enhancing surgical outcomes.
  • Prior to TISSIUM, Crisman served as President of MCE Sales Performance, LLC, where responsibilities included driving sales performance and operational excellence from March 2022 to December 2024.
  • Previously held the position of Vice President for North America Sales at Axogen from January 2019 to January 2022, where focus was placed on expanding market presence and driving revenue growth in the surgical nerve repair sector.
  • Contributed to the growth of LUCERNO DYNAMICS, LLC as Chief Commercial Officer from January 2017 to January 2018 by enhancing commercial strategies and market penetration.
  • Served as Senior Vice President of Global Peripheral Vascular at AngioDynamics from January 2015 to January 2017, where the role involved overseeing global sales strategies and partnerships in the vascular intervention market.
  • From January 2012 to January 2015, held the position of VP Sales & Marketing at Edwards Lifesciences, responsible for leading sales and marketing initiatives for medical technologies.
  • Crisman has held various key leadership roles in prominent medical technology companies, including Boston Scientific and Medtronic, indicating a strong background in the medical device and technology sector.
  • The cumulative experiences and leadership roles reflect a commitment to driving innovation and improving patient care through advanced medical technology solutions.